1. Home
  2. BOX vs OGN Comparison

BOX vs OGN Comparison

Compare BOX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$29.15

Market Cap

4.1B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$8.09

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
OGN
Founded
2005
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
1.8B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
BOX
OGN
Price
$29.15
$8.09
Analyst Decision
Buy
Hold
Analyst Count
9
5
Target Price
$38.67
$14.10
AVG Volume (30 Days)
1.9M
4.6M
Earning Date
12-02-2025
02-12-2026
Dividend Yield
N/A
1.07%
EPS Growth
54.13
N/A
EPS
1.24
1.91
Revenue
$1,150,898,000.00
$6,301,000,000.00
Revenue This Year
$9.07
N/A
Revenue Next Year
$7.74
N/A
P/E Ratio
$23.03
$3.89
Revenue Growth
7.21
N/A
52 Week Low
$28.00
$6.18
52 Week High
$38.80
$17.23

Technical Indicators

Market Signals
Indicator
BOX
OGN
Relative Strength Index (RSI) 40.72 68.91
Support Level $29.42 $7.08
Resistance Level $30.66 $7.21
Average True Range (ATR) 0.61 0.26
MACD -0.10 0.12
Stochastic Oscillator 35.02 97.48

Price Performance

Historical Comparison
BOX
OGN

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: